arterial tortuosity syndrome
Recently Published Documents


TOTAL DOCUMENTS

87
(FIVE YEARS 20)

H-INDEX

16
(FIVE YEARS 2)

BMC Neurology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Stefano Cotti Piccinelli ◽  
Enrico Premi ◽  
Sonia Bonacina ◽  
Nicola Gilberti ◽  
Veronica Vergani ◽  
...  

Abstract Background Arterial Tortuosity Syndrome (ATS) is a rare autosomal recessive disorder characterized by elongated and tortuous arteries. Although ATS showed a significant clinical and pathophysiological overlap with other syndromes involving connective tissues, only few cases of cerebrovascular events related to this syndrome have been described so far. Case presentation We report the case of a 33-years-old male diagnosed with ATS since childhood, that experienced three sudden episodes of expressive aphasia and right hemiparesis with spontaneous resolution. He was treated with recombinant tissue plasminogen activator (r-TPA) at a dosage of 0.9 mg/kg with a complete recovery. Brain Magnetic Resonance Imaging (MRI) showed the absence of acute ischemic lesions and the patient was diagnosed with recurrent transient ischemic attacks (TIA). Intracranial and supra-aortic trunks Magnetic Resonance Angiography (MRA) and Angio-CT scan of the thoracic and abdominal aorta showed marked vessel tortuosity without stenosis. To our knowledge, this is the first reported case of an ATS patient with TIA in young age that was treated with intravenous thrombolysis with recombinant plasminogen activator. Conclusion Our report strengthens the relationship between ATS and juvenile cerebrovascular events, suggesting that an extensive study of body vessels in order to detect potential stenoses or occlusions in these cases is needed. The greater predisposition to cerebrovascular events in ATS could benefit from a more aggressive primary and secondary prevention therapy.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Meiling Liang ◽  
Huaxuan Wen ◽  
Shengli Li

Abstract Background Arterial tortuosity syndrome (ATS) is a rare autosomal recessive connective tissue disorder chiefly characterized by elongated and tortuosity of the large and medium sized arteries and anomalies of the vascular elastic fibers. Here we reported cases of brother about ATS from the same family on the prenatal ultrasound diagnosis. Reports of this case are rare in antenatally and we draw the vessel simulated diagram to display visually. Case presentation Prenatal ultrasound scanning at 29 weeks of gestation of the first fetus showed obvious tortuous and elongated of the aortic arch, ductus arteriosus, left and right pulmonary arteries, carotid and subclavian arteries. Three months after delivery, Contrast-enhanced computed tomography images (CTA) were performed to clearly display vascular abnormalities consistent with prenatal diagnosis of ultrasound. Whole exome sequencing (WES) was performed eight months after birth, two heterozygous variants of SLC2A10 gene was detected in newborn and their father and mother, respectively. Prenatal ultrasound scan at 22 weeks of gestation of the second fetus showed similar cardiovascular imaging. After birth the siblings have facial characteristic features gradually as aging. No surgical intervention was performed in the siblings follow up 19 months. Conclusions The key points of prenatal ultrasound diagnosis of ATS are the elongation and tortuosity of the large and medium sized arteries. Genetic counseling is the process of providing individuals and families with information on the nature, inheritance, and implications of genetic disorders to help them make informed medical and personal decisions.


Author(s):  
PRIYADARSHINI ARUNAKUMAR ◽  
Varun Marimuthu ◽  
Usha MK ◽  
Jayaranganath M

A rare autosomal recessive condition, Arterial tortuosity syndrome (ATS) presents with ectactic blood vessels, cutaneous laxity, and bowel rupture. We report a case of an asymptomatic infant with arterial tortuosity syndrome who presented with left ventricular hypertrophy without any obvious obstruction to the outflow tract.


Author(s):  
Abdulaziz Alkhaldi ◽  
Tarek Momenah ◽  
Atif Alsahari ◽  
Abdulmajeed Alotay ◽  
Juan J. Alfonso ◽  
...  

2020 ◽  
Vol 30 (12) ◽  
pp. 1960-1963
Author(s):  
G. Ricciardi ◽  
V. Sojak ◽  
M. G. Hazekamp

AbstractWe present the case of a child with arterial tortuosity syndrome, describing the operative findings and our surgical technique to address pulmonary arteries stenosis.


2020 ◽  
Vol 30 (11) ◽  
pp. 1738-1740
Author(s):  
Sakethram Saravu Vijayashankar ◽  
J. A. Gordon Culham ◽  
Shreya Moodley

AbstractArterial tortuosity syndrome (ATS) is a rare, autosomal recessive, connective tissue disorder. It predominantly involves the arterial tree with clinical features reflecting the systems involved. There have been few cases of ATS suspected during antenatal screening ultrasound in high-risk families, but none confirmed. We present the first case of ATS confirmed antenatally in the fetus with cascade testing, detecting the disease in the mother as well.


2020 ◽  
Vol 73 (6) ◽  
pp. 504-506
Author(s):  
Jorge Rodríguez-Capitán ◽  
Manuel Macías-Benítez ◽  
Lourdes Conejo-Muñoz ◽  
Antonio Cordero-Aguilar ◽  
Raúl López-Salguero ◽  
...  

2020 ◽  
Vol 29 (9) ◽  
pp. 1476-1488
Author(s):  
Annekatrien Boel ◽  
Joyce Burger ◽  
Marine Vanhomwegen ◽  
Aude Beyens ◽  
Marjolijn Renard ◽  
...  

Abstract Arterial tortuosity syndrome (ATS) is a recessively inherited connective tissue disorder, mainly characterized by tortuosity and aneurysm formation of the major arteries. ATS is caused by loss-of-function mutations in SLC2A10, encoding the facilitative glucose transporter GLUT10. Former studies implicated GLUT10 in the transport of dehydroascorbic acid, the oxidized form of ascorbic acid (AA). Mouse models carrying homozygous Slc2a10 missense mutations did not recapitulate the human phenotype. Since mice, in contrast to humans, are able to intracellularly synthesize AA, we generated a novel ATS mouse model, deficient for Slc2a10 as well as Gulo, which encodes for L-gulonolactone oxidase, an enzyme catalyzing the final step in AA biosynthesis in mouse. Gulo;Slc2a10 double knock-out mice showed mild phenotypic anomalies, which were absent in single knock-out controls. While Gulo;Slc2a10 double knock-out mice did not fully phenocopy human ATS, histological and immunocytochemical analysis revealed compromised extracellular matrix formation. Transforming growth factor beta signaling remained unaltered, while mitochondrial function was compromised in smooth muscle cells derived from Gulo;Slc2a10 double knock-out mice. Altogether, our data add evidence that ATS is an ascorbate compartmentalization disorder, but additional factors underlying the observed phenotype in humans remain to be determined.


Sign in / Sign up

Export Citation Format

Share Document